Pneumoconioses (talcosis, asbestosis, silicosis) and pleural plaques have long been associated with the large tremolitic talc deposit in upstate New York. We have recently studied autopsies (n=17) or biopsies (n=3) from men exposed from 0.4 to 39 yrs (from 1925-1990, most after 1950), including lung cancer (n=7) and mesothelioma cases (n=3). Fourteen were part of a NIOSH cohort [the source of cumulative exposure (EXP) data (in mppcf-yrs)], while 6 worked exclusively at mines not part of the cohort. Asbestosis (FIBR) was diagnosed and graded using standard criteria. Electron microprobe quantitative analysis (QA) of lung burden (LB) was done using in situ QA for non-fibrous (n=14) and digestion QA for fibrous (n=12) particles. Ranges (medians) include: age 39-76 (59); EXP 2.3-341 (48); LB 6.3x10(6) - 1.8x10(11) [2.6x10(8)] total fibers/g dry lung. Correlations with p<0.05 were observed between, e.g.,: EXP and LB of non-fibrous talc, fibrous (asbestiform) talc, FIBR; FIBR and fibrous talc. Within this sample of cases, there was no demonstrable qualitative or quantitative difference in the LB or pathology between cases from the cohort and others. Asbestiform talc and tremolite fibers form a major portion (mean=43%) of the LB; cleavage fragments are also present. These data support a dose-response relationship between EXP and LB of asbestiform, non-asbestiform particles and fibrosis, and between LB and fibrosis. Relationships between measured EXP, LB and FIBR were similar to those observed in other asbestos workers. Our data do not resolve the question of increased risk of lung cancer related to these exposures. Most cohort cases had mining exposures in addition to those estimated by NIOSH. This complexity may in part explain some of the contradictory epidemiologic analyses reported by others.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.